📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
73 announcements match the current filters (relevance ≥ 5).
UGRO Capital Receives RBI No-Objection for Merger with Subsidiary Profectus Capital
UGRO Capital has secured a 'No Objection' from the Reserve Bank of India (RBI) for the amalgamation of its wholly-owned subsidiary, Profectus Capital Private Limited, into itself. This regulatory clearance, received on February 25, 2026, follows the board's approval of the scheme on January 8, 2026. The merger is intended to simplify the organizational structure and integrate business operations. The process now moves toward obtaining approvals from the National Company Law Tribunal (NCLT), stock exchanges, and relevant stakeholders.
Key Highlights
RBI issued 'No Objection' letter on February 25, 2026, for the proposed amalgamation.
The scheme involves merging Profectus Capital Private Limited, a 100% subsidiary, into UGRO Capital.
The application for RBI clearance was submitted on January 9, 2026, following board approval.
Final implementation remains subject to NCLT, stock exchange, and shareholder approvals.
👀 What to Watch
This is a positive regulatory milestone that reduces execution risk for the merger. Investors should maintain their positions while watching for the NCLT's final order.
UGRO Capital Q3 FY26 Consolidated PAT Rises 23% to ₹46 Cr; AUM Hits ₹15,454 Cr
UGRO Capital reported a 40% YoY growth in consolidated AUM to ₹15,454 crores for Q3 FY26, significantly boosted by the Profectus acquisition. Consolidated PAT increased 23% YoY to ₹46 crores, while the company maintained stable asset quality with a Gross NPA of 2.2%. Management is implementing a ₹220 crore cost rationalization plan and pivoting towards high-yield emerging market LAP and embedded finance. This strategic shift aims to reduce dependence on co-lending income and build a more predictable annuity-led interest income profile.
Key Highlights
Consolidated AUM reached ₹15,454 crores, representing 40% YoY and 26% QoQ growth.
Consolidated PAT grew 23% YoY to ₹46 crores, despite a temporary dip in standalone profits due to asset assignment timing.
Asset quality remained healthy with Gross NPA at 2.2%, Net NPA at 1.4%, and collection efficiency at 99%.
Annualized cost rationalization of ₹220 crores is underway, with 50% of the target already achieved.
Cost of borrowing decreased to 10.24% from 10.37% in the previous quarter, aided by easing macro conditions.
👀 What to Watch
Investors should view the shift towards high-yield direct lending and cost-cutting measures as a positive for long-term profitability. Monitor the execution of the Profectus integration and the resulting margin expansion in upcoming quarters.
UGRO Capital Clarifies Q3 Standalone PAT Decline; Consolidated PAT Robust at ₹46.27 Crore
UGRO Capital issued a clarification regarding its Q3 FY26 standalone Profit After Tax (PAT), which dropped significantly to ₹6.38 crore from ₹43.31 crore in the previous quarter. The company explained that this decline was due to Direct Assignment (DA) transactions being executed through its subsidiary, Profectus Capital, to capture better pricing. Consequently, the consolidated PAT for the quarter remained strong at ₹46.27 crore. Management emphasizes that consolidated financials provide the only accurate view of the company's performance and underlying profitability.
Key Highlights
Standalone PAT fell by ₹36.94 crore quarter-on-quarter to ₹6.38 crore in Q3 FY26.
Consolidated PAT for Q3 FY26 stood at ₹46.27 crore, reflecting the impact of subsidiary operations.
Net gain on derecognition of financial instruments (standalone) decreased from ₹100.63 crore to ₹66.18 crore.
Total consolidated income for the quarter reached ₹506.38 crore, significantly higher than standalone income of ₹448.34 crore.
Management advises analysts and investors to use consolidated results for all future comparative evaluations.
👀 What to Watch
Investors should focus on consolidated financial metrics rather than standalone figures to avoid being misled by internal transaction routing between the parent and its subsidiary. The underlying business remains profitable despite the optical decline in standalone PAT.
UGRO Capital Q3 FY26: PAT Rises 23% YoY to ₹46.3 Cr; AUM Grows 40% to ₹15,454 Cr
UGRO Capital reported a robust performance for Q3 FY26, with Assets Under Management (AUM) growing 40% YoY to reach ₹15,454 Cr. Net Profit (PAT) increased by 23% YoY to ₹46.3 Cr, driven by a 19% growth in Net Total Income. The company demonstrated improved operational efficiency with collection efficiency rising to 99% and the cost of borrowing declining to 10.24%. While GNPA saw a marginal uptick to 2.2%, the overall asset quality remains stable with NNPA at 1.4%.
Key Highlights
AUM increased by 40% YoY to ₹15,454 Cr, with Q3 disbursements at ₹2,217 Cr.
Net Profit (PAT) grew 23% YoY to ₹46.3 Cr; Net Total Income rose 19% to ₹259.7 Cr.
Cost of borrowing improved to 10.24% from 10.68% in the previous year's quarter.
Asset quality remains healthy with GNPA at 2.2% and NNPA at 1.4%.
Collection efficiency reached 99% in Q3 FY26, up from 96% in Q3 FY25.
👀 What to Watch
Investors should take confidence in the strong AUM growth and improving borrowing costs, which signal efficient scaling of the MSME lending model. The stock remains a growth play in the NBFC space, though asset quality trends in the 'Business Loan' segment (5.3% GNPA) warrant close monitoring.
UGRO Capital Q3 FY26: AUM Surges 40% YoY to ₹15,454 Cr; Net Profit Rises 23%
UGRO Capital delivered a robust performance in Q3 FY26, with Assets Under Management (AUM) growing 40% YoY to ₹15,454 crore. Net profit for the quarter rose 23% YoY to ₹46.3 crore, while total income increased by 32% to ₹506.4 crore. Despite the growth, Return on Assets (RoA) moderated slightly to 2.2% from 2.5% YoY. The company maintained stable asset quality with GNPA at 2.2% and improved its cost of borrowing to 10.24%.
Key Highlights
AUM grew by 40% YoY to ₹15,454 Cr with net disbursements of ₹2,217 Cr in Q3 FY26.
Net Profit (PAT) increased 23% YoY to ₹46.3 Cr, while total income rose 32% to ₹506.4 Cr.
Asset quality remained stable with GNPA at 2.2% and NNPA at 1.4% as of December 2025.
Cost of borrowing decreased to 10.24% from 10.68% in the previous year's corresponding quarter.
Collection efficiency improved to 99% compared to 96% in Q3 FY25.
👀 What to Watch
The stock remains a growth play in the MSME lending space with strong AUM momentum and improving liability costs. Investors should watch for RoE expansion as the company scales its high-yielding product segments and optimizes its off-book strategy.
Ugro Capital Q3 FY26: AUM Grows 40% YoY to ₹15,454 Cr; PAT Up 23% to ₹46.3 Cr
Ugro Capital reported a robust 40% YoY growth in Assets Under Management (AUM), reaching ₹15,454 Cr for the quarter ended December 2025. Net profit (PAT) increased by 23% YoY to ₹46.3 Cr, driven by a 19% rise in Net Total Income to ₹259.7 Cr. While GNPA saw a marginal uptick to 2.2%, NNPA improved to 1.4%, and collection efficiency remained strong at 99%. The company successfully reduced its cost of borrowings to 10.24%, down from 10.68% a year ago.
Key Highlights
AUM surged 40% YoY to ₹15,454 Cr with net disbursements of ₹2,217 Cr in Q3 FY26.
Profit After Tax (PAT) grew 23% YoY to ₹46.3 Cr, while PBT rose 19% to ₹63.0 Cr.
Asset quality remains stable with GNPA at 2.2% and NNPA improving to 1.4% from 1.5% YoY.
Cost of borrowings improved to 10.24% from 10.68% YoY, reflecting a diversified lender base.
Off-book AUM stands at 36%, supported by partnerships with 16 co-lenders.
👀 What to Watch
Investors should take note of the strong AUM growth and improving cost of funds as signs of successful scaling. The stock remains attractive for those looking for MSME-focused lending exposure, though the high cost-to-income ratio of 58.1% warrants monitoring.
Ugro Capital Q3 FY26 PAT Drops 83% YoY to ₹6.38 Cr; Nominee Director Resigns
Ugro Capital reported a sharp decline in standalone net profit for Q3 FY26, falling to ₹6.38 crore from ₹37.51 crore in the same quarter last year. While total income grew 16.5% YoY to ₹448.34 crore, the bottom line was severely impacted by a 41% surge in finance costs and a 45% increase in impairment provisions. Additionally, the company announced the resignation of Nominee Director Chetan Gupta and the proposed appointment of Ramanathan Subramanian Arun Kumar as a new Nominee Director for ClearSky Investment Holdings.
Key Highlights
Standalone Net Profit plummeted 83% YoY to ₹6.38 crore in Q3 FY26 from ₹37.51 crore in Q3 FY25.
Total Income increased by 16.5% YoY to ₹448.34 crore, though it declined slightly on a QoQ basis from ₹461.18 crore.
Finance costs rose significantly to ₹236.55 crore, up 41% from ₹167.31 crore in the year-ago period.
Impairment on financial instruments (provisions) increased to ₹59.97 crore compared to ₹41.28 crore in Q3 FY25.
Chetan Gupta resigned as Non-Executive Nominee Director; Ramanathan Subramanian Arun Kumar to be appointed as Nominee Director for ClearSky Investment Holdings.
👀 What to Watch
Investors should exercise caution as the sharp drop in profitability and rising impairment costs suggest pressure on margins and asset quality. Monitor management's commentary regarding the spike in finance costs and the outlook for credit losses in the coming quarters.
UGRO Capital Announces Strategic Realignment; Targets ₹220 Cr Annual Cost Savings
UGRO Capital is shifting its business model to focus on high-yield Emerging Market secured lending and Embedded merchant financing, while exiting low-yield, DSA-led channels. The company has identified ₹220 crore in annualized operating cost savings through structural rationalization and overhead optimization. This realignment aims to increase recurring interest income and improve earnings quality, targeting a sustainable ROA of 3-3.5%. Management expects no further equity dilution for the next three years, as growth will be funded primarily through internal accruals.
Key Highlights
Identified ₹220 crore in annualized operating cost savings through exit of DSA-led verticals and overhead optimization.
AUM grew to ₹15,454 crore as of Dec-25, with a target to have 73-85% of AUM in high-yield segments by FY28-29.
Strategic exit from low-yield Prime LAP and Machinery loans to focus on segments with an average yield of 19%.
No equity capital requirement for the next 3 years; future growth to be funded via internal accruals.
Emerging Market branch network expanded to 300+ locations with a focus on improving branch productivity to ₹0.80-0.85 Cr per month.
👀 What to Watch
Investors should view this as a positive move toward better margins and capital efficiency, though they should monitor the execution of cost-cutting measures. The commitment to avoid equity dilution for three years provides a strong floor for valuation.
UGRO Capital Q3 FY26: AUM Up 40% YoY to INR 15,454 Cr; PAT Rises 23% to INR 46.3 Cr
UGRO Capital reported a strong 40% YoY growth in AUM to INR 15,454 crore for Q3 FY26, driven by its high-yielding Emerging Market and Embedded Finance verticals. The company's quarterly PAT rose 23% YoY to INR 46.3 crore, while total income grew 32% to INR 506.4 crore. Asset quality remained stable with GNPA at 2.2% and NNPA at 1.4%, supported by a 45% provision coverage ratio. Notably, the acquisition of Profectus Capital was completed in December 2025, making it a 100% subsidiary.
Key Highlights
AUM reached INR 15,454 crore, marking a significant 40% YoY increase.
Net Profit (PAT) for Q3 FY26 stood at INR 46.3 crore, up 23% from the previous year.
Embedded Finance AUM grew to INR 1,798 crore within just five quarters of launch.
Asset quality remains healthy with GNPA at 2.2% and NNPA at 1.4% on total AUM.
Completed the strategic acquisition of Profectus Capital in December 2025.
👀 What to Watch
Investors should monitor the integration of Profectus Capital and the continued scaling of high-yield segments like Embedded Finance. The stable asset quality despite rapid growth is a positive indicator for the company's risk management.
UGRO Capital Q3 FY26 PAT Drops 83% YoY to ₹6.38 Cr Despite 16.5% Revenue Growth
UGRO Capital reported a significant decline in profitability for Q3 FY26, with standalone PAT falling to ₹6.38 crore from ₹37.51 crore in the same quarter last year. While total income grew by 16.5% YoY to ₹448.34 crore, the bottom line was pressured by a sharp rise in finance costs, which surged 41% to ₹236.55 crore. Impairment charges also rose significantly to ₹59.97 crore, up from ₹41.28 crore YoY. On the management front, the board approved the appointment of Ramanathan Subramanian Arun Kumar as a nominee director following the resignation of Chetan Gupta.
Key Highlights
Standalone Net Profit for Q3 FY26 plummeted 83% YoY to ₹6.38 crore from ₹37.51 crore.
Total Income for the quarter stood at ₹448.34 crore, a 16.5% increase compared to ₹384.96 crore in Q3 FY25.
Finance costs increased sharply to ₹236.55 crore from ₹167.31 crore in the year-ago period.
Impairment on financial instruments rose to ₹59.97 crore, reflecting higher provisioning requirements.
Basic EPS for the quarter fell to ₹0.45 from ₹4.05 in the corresponding quarter of the previous year.
👀 What to Watch
Investors should be cautious as the sharp contraction in margins and rising impairment costs indicate significant operational headwinds. Monitor management's guidance on cost of funds and credit quality in the upcoming quarters before making new positions.
UGRO Capital Q3 FY26 PAT Drops 83% YoY to ₹6.38 Cr Amid Rising Finance and Impairment Costs
UGRO Capital reported a sharp decline in profitability for Q3 FY26, with Net Profit (PAT) falling to ₹6.38 crore from ₹37.51 crore in the same quarter last year. While total income grew 16.5% YoY to ₹448.34 crore, the bottom line was severely impacted by a surge in finance costs to ₹236.55 crore and higher impairment charges of ₹59.97 crore. Sequentially, the performance was even weaker, with PAT plummeting from ₹43.31 crore in Q2 FY26. The company also saw a change in its board, with the resignation of nominee director Chetan Gupta and the appointment of Ramanathan Subramanian Arun Kumar.
Key Highlights
Net Profit (PAT) for Q3 FY26 stood at ₹6.38 crore, a massive 83% decline compared to ₹37.51 crore in Q3 FY25.
Total Income for the quarter rose 16.5% YoY to ₹448.34 crore, but declined slightly from ₹461.18 crore in Q2 FY26.
Impairment on financial instruments increased to ₹59.97 crore, up from ₹41.28 crore in the year-ago period.
Finance costs surged to ₹236.55 crore in Q3 FY26, representing a 41% increase over Q3 FY25.
9M FY26 PAT reached ₹83.82 crore, trailing the ₹103.38 crore achieved in the first nine months of the previous fiscal year.
👀 What to Watch
Investors should exercise caution as the sharp drop in quarterly profits and rising credit costs indicate significant margin pressure. It is advisable to wait for management commentary regarding asset quality and the outlook for borrowing costs before making new positions.
Ugro Capital Assigned 'CareEdge B+/Stable' Rating for USD 50 Million ECB
CareEdge Global has assigned a 'CareEdge B+/Stable' rating to Ugro Capital's USD 50 million External Commercial Borrowing. The company's AUM stood at ₹12,226 crore as of September 2025, which increased to approximately ₹15,500 crore following the acquisition of Profectus Capital in December 2025. While the portfolio is 70% secured, profitability remains modest with an ROA of 1.9% for FY25, impacted by high operating costs of 3.6%. Investors should note the elevated leverage of 5.5x (including off-book) and a Capital Adequacy Ratio that recently dipped to 19.4%, close to covenant thresholds.
Key Highlights
Assigned 'CareEdge B+/Stable' rating for a USD 50 million External Commercial Borrowing (ECB).
Combined AUM reached ~₹15,500 crore post-acquisition of Profectus Capital's ₹3,400 crore book.
Asset quality metrics reported with GNPA at 3.0% and NNPA at 1.7% as of September 30, 2025.
Operating costs are high at 3.6% of managed assets, with management targeting improvements by FY27.
Capital Adequacy Ratio (CAR) stood at 19.4% in March 2025, leaving a thin buffer against 20% debt covenants.
👀 What to Watch
Investors should monitor the company's progress in reducing operating expenses and improving ROA post-merger. The thin capital buffer suggests a potential need for further equity infusion to support aggressive growth targets.
Ugro Capital Rating Reaffirmed at 'A'; Profectus Acquisition to Boost AUM to ₹15,400 Cr
Acuité Ratings has reaffirmed and withdrawn the 'ACUITE A' rating for ₹156.28 Cr of NCDs following redemption and issuer request. More importantly, the rating has been removed from 'Rating Watch' as Ugro Capital successfully completed the acquisition of Profectus Capital, which brings an AUM of ~₹3,400 Cr. The combined entity is expected to reach an AUM of ₹15,400 Cr, representing a 29% growth with a more robust 75% secured asset mix. While asset quality has improved with GNPA at 2.35%, the company's return on average assets (RoAA) remains moderate at 1.86%.
Key Highlights
Acquisition of Profectus Capital completed, projected to increase total AUM by 29% to ₹15,400 Cr.
On-book GNPA improved to 2.35% as of March 31, 2025, compared to 3.09% in the previous year.
Combined entity asset mix to shift towards 75% secured and 25% unsecured loans for better diversification.
Planned equity raise of ₹1,315 Cr for FY2026 via rights issue and Compulsorily Convertible Debentures (CCDs).
FY2025 PAT reported at ₹143.93 Cr with a moderate RoAA of 1.86% and gearing at 3.37 times.
👀 What to Watch
The completion of the Profectus acquisition is a major milestone that improves the company's scale and asset quality profile. Investors should monitor the integration process and look for improvements in the RoAA as the combined entity scales.
UGRO Capital Allots 3.89 Lakh Equity Shares Following CCD Conversion at Rs 185/Share
UGRO Capital has approved the allotment of 3,89,183 equity shares of face value Rs. 10 each to CCD holders who exercised their conversion rights. This conversion is part of the company's larger INR 534.64 crore capital raise initiated in October 2025 via preferential allotment. The conversion price was fixed at Rs. 185 per share, which includes a premium of Rs. 175. As a result, the company's total paid-up equity share capital has increased from 15.47 crore to 15.51 crore shares.
Key Highlights
Allotment of 3,89,183 equity shares pursuant to conversion of Compulsorily Convertible Debentures (CCDs)
Conversion price of Rs. 185 per share including a premium of Rs. 175
Total paid-up equity capital increased to 15,50,95,936 shares from 15,47,06,753 shares
Part of a larger INR 534.64 crore capital raise through preferential allotment
New equity shares will rank pari-passu with existing shares in all respects
👀 What to Watch
Investors should account for the marginal equity dilution resulting from this conversion. The focus should remain on how the company utilizes the total capital raised to expand its AUM and improve net interest margins.
UGRO Capital to Merge Subsidiary Profectus Capital; Increases CP Borrowing Limit to ₹800 Cr
UGRO Capital's board has approved the merger of its wholly-owned subsidiary, Profectus Capital Private Limited (PCPL), into the parent company to streamline operations and enhance its MSME lending portfolio. PCPL brings a significant net worth of ₹1,127.85 crore and total assets of ₹3,323.65 crore as of September 2025. Since PCPL is a 100% subsidiary, no new shares will be issued, ensuring zero equity dilution for existing shareholders. Additionally, the company has increased its Commercial Paper borrowing limit from ₹500 crore to ₹800 crore to bolster liquidity.
Key Highlights
Merger of wholly-owned subsidiary Profectus Capital (PCPL) with UGRO Capital approved by the Board.
PCPL reported H1 FY26 revenue of ₹216.38 crore and a net worth of ₹1,127.85 crore.
UGRO Capital's standalone assets stood at ₹10,778.76 crore as of September 30, 2025.
Zero equity dilution for shareholders as all PCPL shares held by UGRO will be cancelled.
Commercial Paper borrowing limit increased by 60% from ₹500 crore to ₹800 crore.
👀 What to Watch
Investors should view this as a positive consolidation that simplifies the corporate structure and improves capital efficiency without diluting equity. Monitor the progress of NCLT and RBI approvals for the merger timeline.
UGRO Capital to Merge Profectus Capital; Increases CP Borrowing Limit to ₹800 Crore
UGRO Capital's board has approved the merger of its wholly-owned subsidiary, Profectus Capital Private Limited (PCPL), into the parent company to streamline operations and enhance capital efficiency. PCPL, which focuses on MSME lending, reported a revenue of ₹417.42 crore and a net worth of ₹1,119.18 crore for FY25. Additionally, the company has increased its borrowing limit for Commercial Papers from ₹500 crore to ₹800 crore to support liquidity and growth. Since PCPL is a 100% subsidiary, no new shares will be issued, and the equity shareholding pattern of UGRO Capital will remain unchanged.
Key Highlights
Board approved the Scheme of Amalgamation of wholly-owned subsidiary Profectus Capital Private Limited (PCPL) with UGRO Capital.
PCPL reported total assets of ₹3,577.66 crore and a net worth of ₹1,119.18 crore as of March 31, 2025.
Commercial Paper borrowing limit increased by 60%, from ₹500 crore to ₹800 crore.
No equity dilution will occur as the merger involves a 100% subsidiary; shares held by UGRO in PCPL will be cancelled.
The merger aims to achieve operational synergies, reduce regulatory compliance costs, and strengthen the secured asset mix.
👀 What to Watch
Investors should view this consolidation as a positive step toward improving operational efficiency and capital utilization without equity dilution. Monitor the progress of regulatory approvals from NCLT and RBI for the merger completion.
UGRO Capital Re-opens Series 2 Non-Convertible Debentures (NCD) Issuance of INR 100 Crores
UGRO Capital has decided to re-open its Series 2 Non-Convertible Debentures (NCD) issuance, aggregating to INR 100 Crores. This decision follows a very recent withdrawal of the same issuance announced on December 22, 2025. The quick reversal suggests a stabilized plan for debt-based capital infusion. The funds are expected to support the company's lending operations and growth in the MSME sector.
Key Highlights
Re-opening of Series 2 Non-Convertible Debentures (NCD) issuance for INR 100 Crores.
The decision follows a withdrawal notice previously issued on December 22, 2025.
The issuance is being conducted under Regulation 30 and 51 of SEBI LODR Regulations.
The capital raise is aimed at strengthening the balance sheet for further credit disbursement.
👀 What to Watch
Investors should monitor the final coupon rates and tenure of these NCDs to assess the company's cost of funds. The successful closure of this INR 100 Crore raise will be a positive indicator of liquidity management.
UGRO Capital Withdraws Proposed Series 2 Non-Convertible Debenture (NCD) Issuance
UGRO Capital has announced the withdrawal of its proposed issuance of Non-Convertible Debentures (NCDs) under Series 2. This decision follows a previous approval by the Investment and Borrowing Committee on December 17, 2025, for a private placement of listed, rated, senior debt. The company cited 'internal considerations' as the reason for cancelling this specific series of the fundraise. Investors should note that this affects only the Series 2 tranche of the previously planned debt issuance.
Key Highlights
Withdrawal of Series 2 NCD issuance previously approved on December 17, 2025
The proposed instruments were listed, rated, senior, secured/unsecured NCDs
Decision to withdraw was based on unspecified internal considerations
The issuance was originally planned on a private placement basis
👀 What to Watch
Investors should monitor if the company announces alternative fundraising plans or if this withdrawal indicates a change in their immediate capital requirements. Observe the company's liquidity position in upcoming quarterly reports to ensure lending growth remains on track.
Ugro Capital Credit Rating Affirmed at 'A+'; Outlook Revised to Positive by India Ratings
India Ratings has affirmed Ugro Capital's long-term rating at 'IND A+' and revised the outlook to 'Positive' from 'Rating Watch', while CRISIL reaffirmed 'CRISIL A/Stable'. This resolution follows the successful acquisition of Profectus Capital (PCPL), which is expected to increase the consolidated Assets Under Management (AUM) to approximately ‑150 billion. The company recently strengthened its balance sheet with a ‑9.1 billion capital raise via CCDs and rights issues, maintaining a healthy capital adequacy ratio of 25.4%. The rating actions reflect improved product diversification and a strategic shift towards a higher proportion of secured lending.
Key Highlights
India Ratings upgraded the outlook to 'Positive' from 'Rating Watch' for Bank Loans and NCDs.
Consolidated AUM is projected to reach ‑150 billion following the PCPL acquisition, up from ‑122 billion in 1HFY26.
Post-acquisition, the share of secured assets in the portfolio is expected to rise to nearly 85% from 78%.
Capital adequacy remains robust at 25.4% with a leverage ratio of 3.3x as of Q2 FY26.
The company has diversified its funding base to 59 lenders, including major public and private sector banks.
👀 What to Watch
The outlook upgrade to 'Positive' is a significant endorsement of the company's post-merger stability and could lead to lower borrowing costs. Investors should monitor the successful integration of PCPL and the impact of operational synergies on profitability margins.
Ugro Capital Allots 5.34 Lakh Shares on CCD Conversion; 2.04 Cr Warrants Lapse
Ugro Capital has approved the allotment of 5,34,088 equity shares following the mandatory conversion of Compulsorily Convertible Debentures (CCDs) at a price of Rs. 264 per share. This move increases the company's total paid-up equity capital to 15,47,06,753 shares. Significantly, 2,04,88,631 warrants issued in June 2024 have lapsed as they were not exercised within the 18-month tenure. The company also corrected a previous filing, noting that 1,74,54,450 warrants from an earlier tranche had also lapsed.
Key Highlights
Allotment of 5,34,088 equity shares at a conversion price of Rs. 264 (including Rs. 254 premium)
Paid-up equity capital increased from Rs. 154.17 crore to Rs. 154.71 crore
Lapse of 2,04,88,631 warrants issued on June 18, 2024, due to non-exercise by holders
Correction of previously reported lapsed warrants from June 6, 2024, to 1,74,54,450 units
The conversion was mandatory following the expiry of the 18-month tenure of the CCDs
👀 What to Watch
Investors should account for the minor equity dilution and the fact that a large portion of the potential warrant-led capital infusion has lapsed. Monitor the company's capital adequacy and future fund-raising plans to support growth.
